|
|
Blood, 1 February 2006, Vol. 107, No. 3, pp. 1010-1017.
Prepublished online as a Blood First Edition Paper on October 13, 2005; DOI 10.1182/blood-2005-07-2903.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells
Peta J. O'Connell,
Xiangbin Wang,
Matilde Leon-Ponte,
Corrie Griffiths,
Sandeep C. Pingle, and
Gerard P. Ahern
From the Robarts Research Institute, London, ON, Canada; Departments of Surgery, Microbiology and Immunology, University of Western Ontario, London, ON, Canada; and Department of Pharmacology, Georgetown University, Washington, DC.
Adaptive immunity is triggered at the immune synapse, where peptide-major histocompatibility complexes and costimulatory molecules expressed by dendritic cells (DCs) are physically presented to T cells. Here we describe transmission of the inflammatory monoamine serotonin (5-hydroxytryptamine [5-HT]) between these cells. DCs take up 5-HT from the microenvironment and from activated T cells (that synthesize 5-HT) and this uptake is inhibited by the antidepressant, fluoxetine. Expression of 5-HT transporters (SERTs) is regulated by DC maturation, exposure to microbial stimuli, and physical interactions with T cells. Significantly, 5-HT sequestered by DCs is stored within LAMP-1+ vesicles and subsequently released via Ca2+-dependent exocytosis, which was confirmed by amperometric recordings. In turn, extracellular 5-HT can reduce T-cell levels of cAMP, a modulator of T-cell activation. Thus, through the uptake of 5-HT at sites of inflammation, and from activated T cells, DCs may shuttle 5-HT to naive T cells and thereby modulate T-cell proliferation and differentiation. These data constitute the first direct measurement of triggered exocytosis by DCs and reveal a new and rapid type of signaling that may be optimized by the intimate synaptic environment between DCs and T cells. Moreover, these results highlight an important role for 5-HT signaling in immune function and the potential consequences of commonly used drugs that target 5-HT uptake and release.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. Bloom, J. J. Unternaehrer, A. Jiang, J.-S. Shin, L. Delamarre, P. Allen, and I. Mellman
Spinophilin participates in information transfer at immunological synapses
J. Cell Biol.,
June 6, 2008;
181(2):
203 - 211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nakamura, T. Sato, A. Ohashi, H. Tsurui, and H. Hasegawa
Role of a Serotonin Precursor in Development of Gut Microvilli
Am. J. Pathol.,
February 1, 2008;
172(2):
333 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yang, K. Li, P. C. Ng, C. K. Y. Chuen, T. K. Lau, Y. S. Cheng, Y. S. Liu, C. K. Li, P. Man Pan Yuen, A. Edward James, et al.
Promoting Effects of Serotonin on Hematopoiesis: Ex Vivo Expansion of Cord Blood CD34+ Stem/Progenitor Cells, Proliferation of Bone Marrow Stromal Cells, and Antiapoptosis
Stem Cells,
July 1, 2007;
25(7):
1800 - 1806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Leon-Ponte,, G. P. Ahern, and P. J. O'Connell
Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor
Blood,
April 15, 2007;
109(8):
3139 - 3146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cloez-Tayarani and J.-P. Changeux
Nicotine and serotonin in immune regulation and inflammatory processes: a perspective
J. Leukoc. Biol.,
March 1, 2007;
81(3):
599 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pacheco, H. Oliva, J. M. Martinez-Navio, N. Climent, F. Ciruela, J. M. Gatell, T. Gallart, J. Mallol, C. Lluis, and R. Franco
Glutamate Released by Dendritic Cells as a Novel Modulator of T Cell Activation
J. Immunol.,
November 15, 2006;
177(10):
6695 - 6704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Meredith, M. J. Holder, A. Rosen, A. D. Lee, M. J. S. Dyer, N. M. Barnes, and J. Gordon
Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma
PNAS,
September 5, 2006;
103(36):
13485 - 13490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stolk, M. Leon-Ponte, M. Merrill, G. P. Ahern, and P. J. O'Connell
IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1
J. Leukoc. Biol.,
September 1, 2006;
80(3):
651 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Agaugue, L. Perrin-Cocon, F. Coutant, P. Andre, and V. Lotteau
1-Methyl-Tryptophan Can Interfere with TLR Signaling in Dendritic Cells Independently of IDO Activity
J. Immunol.,
August 15, 2006;
177(4):
2061 - 2071.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |